Multiple Organ Dysfunction Syndrome Clinical Trial
Official title:
Key Technology Research of the Comprehensive Treatment of Multiple Organ Dysfunction Syndrome
The multiple organ dysfunction syndrome (MODS) has remained the major factor contributing to prolongation of intensive and mortality. It is reported that the mortality rates have varied between 20% and 100%, depending on number, severity, duration, type and combination, and definition of dysfunction. In our study, the investigators explore some comprehensive treatment technology to improved outcomes of MODS patients.
n/a
Observational Model: Case Control, Time Perspective: Retrospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00430859 -
Bovine Intestinal Alkaline Phosphatase for the Treatment of Patients With Sepsis
|
Phase 2 | |
Recruiting |
NCT01713205 -
Prediction Study of Complications After Severe Trauma
|
||
Recruiting |
NCT01186783 -
Reducing Elevated Heart Rate in Patients With Multiple Organ Dysfunction Syndrome (MODS) by Ivabradine
|
Phase 2 | |
Terminated |
NCT03489577 -
The Role of Post-traumatic Inhibition of the Innate and Adaptive Immune System in the Development of Infectious Complications in Severely Injured Patients
|
||
Completed |
NCT04438460 -
Pediatric Immune Response to Multi-Organ Dysfunction
|
N/A | |
Recruiting |
NCT00908635 -
The Role of Angiopoietin, Tie-2, and Vascular Endothelial Growth Factor (VEGF) in Sepsis-Induced Multiple Organ Dysfunction Syndrome (MODS)
|
N/A | |
Recruiting |
NCT04014413 -
Safety and Efficacy of Fecal Microbiota Transplantation
|
N/A | |
Recruiting |
NCT03552848 -
Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection
|
N/A | |
Enrolling by invitation |
NCT02204215 -
Electric Acupuncture for ICU-acquired Weakness in Mechanical Ventilation Patients
|
N/A | |
Completed |
NCT03019250 -
A Trial of Enteral Colostrum on Clinical Outcomes in Critically Ill Patients
|
N/A | |
Terminated |
NCT01787045 -
Early Physical Therapy in Patients With Sepsis
|
N/A | |
Completed |
NCT02246036 -
Tolerance and Safety of a Duodenal Probe Monitoring the Microcirculation
|
N/A | |
Completed |
NCT03518203 -
Eculizumab to Treat Thrombotic Microangiopathy/Atypical Hemolytic Uremic Syndrome -Associated Multiple Organ Dysfunction Syndrome in Hematopoietic Stem Cell Transplant Recipients
|
Phase 2 | |
Completed |
NCT00736723 -
NT-proBNP in ICU Postoperative/Posttraumatic Patients With Shock
|
N/A | |
Completed |
NCT00736827 -
BK Virus and Renal Dysfunction in Postoperative/Posttraumatic Critically Ill Patients
|
N/A | |
Recruiting |
NCT00127985 -
6-Methyl-Prednisolone for Multiple Organ Dysfunction Syndrome
|
Phase 4 | |
Recruiting |
NCT03589378 -
Therapeutic Plasma Exchange Adsorption Diafiltration
|
N/A | |
Terminated |
NCT01275976 -
Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture
|
Phase 3 |